How does venture capital operate in medical innovation?

Area of Science:

• Health Policy
• Innovation Studies
• Venture Capital Analysis

Background:

• Health policy scholars aim to foster valuable healthcare technologies but may misunderstand venture capital (VC) operations.
• VCs significantly influence the types of health technologies developed and adopted.
• Existing policies often support technologies favored by investors, potentially misaligning with critical health needs.

Purpose of the Study:

• To clarify the operational mandate and influence of venture capitalists in healthcare.
• To examine the congruence between health technology ventures and VC objectives.
• To inform policy recommendations for aligning innovation with healthcare priorities.

Main Methods:

• Drawing on international innovation policy scholarship.
• Utilizing 5-year fieldwork research in Quebec, Canada.
• Analyzing the relationship between VC mandates and health technology development.

Main Results:

• VCs' profit-driven mandate, external to healthcare, tangibly shapes health technologies.
• Variability in venture-VC mandate congruence explains the emergence or non-existence of certain innovations.
• Current policies inadvertently support technologies that may not address pressing health issues.

Conclusions:

• Clinical leaders and health policy scholars should increase their role in innovation policy.
• Public policies should incentivize technologies addressing the needs of the elderly, chronic disease patients, and health disparities.
• Aligning VC investment with societal health needs is crucial for equitable healthcare innovation.